To investigate the synergism of low-doses of amlodipine and irbesartan on reduction of blood pressure variability (BPV), amelioration of baroreflex sensitivity (BRS) and organ protection in ...

We randomly assigned 1715 hypertensive patients with nephropathy due to type 2 diabetes to treatment with irbesartan (300 mg daily), amlodipine (10 mg daily), or placebo. The target blood pressure ...

Amlodipine and hydrochlorothiazide in standalone ... Several pharmaceutical companies have announced recalls of versions of valsartan, irbesartan and losartan. The recalled drugs are part ...

As no studies have been published comparing the effects of irbesartan, amlodipine and standard blood pressure control in ESRD patients, we conservatively assumed that when a patient developed ESRD ...

Irbesartan in combination with amlodipine plus hydrochlorothiazide is used to control high blood pressure, the release states. This recall is the latest in the past few months. Since July ...

In the randomized trial, investigators compared irbesartan (an angiotensin-receptor blocker), amlodipine (a calcium-channel blocker), and placebo. A manufacturer of irbesartan sponsored the trial.

A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent ...